Related Experiment Video
Updated: Jul 5, 2025
12:44
Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023
3.8K
Three-dimensional, in-vitro approaches for modelling soft-tissue joint diseases
Peter A Johnson1, Jessica E Ackerman1, Mariola Kurowska-Stolarska2
1Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
The Lancet. Rheumatology
|January 22, 2024
Summary
Developing advanced 3D in-vitro models is crucial for understanding joint diseases like osteoarthritis. These models promise to accelerate drug discovery and personalize medicine for musculoskeletal conditions.
Area of Science:
- Biomedical Engineering
- Musculoskeletal Research
- Regenerative Medicine
Background:
- Soft tissue joint diseases cause significant global pain and disability.
- Current research models face limitations in preclinical drug discovery.
- In-vitro human tissue models show promise for recapitulating disease pathobiology.
Purpose of the Study:
- To review the need for physiologically relevant 3D in-vitro culture systems for joint diseases.
- To discuss challenges in modeling the joint's complex extracellular matrix.
- To highlight the importance of an organ-level approach for understanding joint tissue crosstalk.
Main Methods:
- Review of current literature on in-vitro models for joint diseases.
- Discussion of challenges in creating 3D culture systems for cartilage, synovium, tendon, and ligament.
- Emphasis on integrating tissue crosstalk in model design.
Main Results:
- Physiologically relevant 3D culture systems are required to advance understanding of joint disease mechanisms.
- Modeling the joint as a whole organ is essential for capturing inter-tissue communication.
- Bespoke in-vitro models can inform functional studies and therapeutic targeting.
Conclusions:
- Advanced 3D in-vitro models can significantly improve the study of soft tissue joint diseases.
- These models offer a pathway to personalized medicine for musculoskeletal disorders.
- Successful development will accelerate therapeutic target discovery and validation.
